Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Conditions: Ewing Sarcoma Interventions: Drug: Irinotecan Hydrochloride Liposome Injection Sponsors: Peking University People ' s Hospital; Peking University Shougang Hospital; Shandong Cancer Hospital and Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer | Cancer & Oncology | Ewing's Sarcoma | Hospitals | Research | Sarcomas